Serveur d'exploration Tocilizumab - Curation (PubMed)

Index « MedMesh.i » - entrée « Health Status »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Health Services Needs and Demand < Health Status < Health Status Indicators  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 20.
Ident.Authors (with country if any)Title
000490 (2019) Vibeke Strand [États-Unis] ; Sophie Dimonaco [Royaume-Uni] ; Katie Tuckwell [États-Unis] ; Micki Klearman [États-Unis] ; Neil Collinson [Royaume-Uni] ; John H. Stone [États-Unis]Health-related quality of life in patients with giant cell arteritis treated with tocilizumab in a phase 3 randomised controlled trial.
000E05 (????) Shin-Ya Kawashiri [Japon] ; Ayako Nishino [Japon] ; Takahisa Suzuki [Japon] ; Yoshikazu Nakashima [Japon] ; Yoshiro Horai [Japon] ; Yukitaka Ueki [Japon] ; Toshiyuki Aramaki [Japon] ; Keita Fujikawa [Japon] ; Munetoshi Nakashima [Japon] ; Akitomo Okada [Japon] ; Kiyoshi Migita [Japon] ; Akinari Mizokami [Japon] ; Naoki Matsuoka [Japon] ; Masanobu Mine [Japon] ; Soko Sakito [Japon] ; Naoki Iwamoto [Japon] ; Kunihiro Ichinose [Japon] ; Mami Tamai [Japon] ; Hideki Nakamura [Japon] ; Tomoki Origuchi [Japon] ; Kiyoshi Aoyagi [Japon] ; Katsumi Eguchi [Japon] ; Atsushi Kawakami [Japon]Rapid improvement of Clinical Disease Activity Index (CDAI) at 3 months predicts a preferable CDAI outcome at 1 year in active rheumatoid arthritis patients treated with tocilizumab: results from an observational investigation of daily clinical practice.
001244 (2015) Maria K. Kvamme [Norvège] ; Elisabeth Lie [Norvège] ; Till Uhlig [Norvège] ; Tron A. Moger [Norvège] ; Tore K. Kvien [Norvège] ; Ivar S. Kristiansen [Norvège]Cost-effectiveness of TNF inhibitors vs synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a Markov model study based on two longitudinal observational studies.
001405 (????) S. Kawashiri [Japon] ; Y. Ueki ; K. Migita ; H. Nakamura ; K. Aoyagi ; A. KawakamiBaseline low modified health assessment questionnaire (MHAQ) predicts the state of remission estimated by clinical disease activity index and MHAQ at 1 year in tocilizumab-treated rheumatoid arthritis patients.
001492 (????) L. Barra [Canada] ; A. Ha ; L. Sun ; C. Fonseca ; J. PopeEfficacy of biologic agents in improving the Health Assessment Questionnaire (HAQ) score in established and early rheumatoid arthritis: a meta-analysis with indirect comparisons.
001735 (2013) Roy M. Fleischmann [Afrique du Sud] ; Anne-Marie Halland ; Marek Brzosko ; Ruben Burgos-Vargas ; Christopher Mela ; Emma Vernon ; Joel M. KremerTocilizumab inhibits structural joint damage and improves physical function in patients with rheumatoid arthritis and inadequate responses to methotrexate: LITHE study 2-year results.
001799 (2013) Yasuhiko Hirabayashi [Japon] ; Tomonori IshiiThe DAS28-ESR cutoff value necessary to achieve remission under the new Boolean-based remission criteria in patients receiving tocilizumab.
001839 (2012) Vibeke Strand [États-Unis] ; Gerd R. Burmester ; Sarika Ogale ; Jenny Devenport ; Ani John ; Paul EmeryImprovements in health-related quality of life after treatment with tocilizumab in patients with rheumatoid arthritis refractory to tumour necrosis factor inhibitors: results from the 24-week randomized controlled RADIATE study.
001853 (2013) Mie Fusama [Japon] ; Hideko Nakahara ; Yoshimasa Hamano ; Masayuki Nishide ; Keisuke Kawamoto ; Takashi Hosokawa ; Satoko Nozato ; Shinji Higa ; Tsuyoshi Igarashi ; Eiji Takeuchi ; Takanori Kuroiwa ; Yasunori Shimaoka ; Masao Yukioka ; Yasushi Miura ; Kayoko Higashi ; Taro Kuritani ; Keiji MaedaImprovement of health status evaluated by Arthritis Impact Measurement Scale 2 (AIMS-2) and Short Form-36 (SF-36) in patients with rheumatoid arthritis treated with tocilizumab.
001879 (2012) Christophe Richez [France] ; Thomas Barnetche ; Liliane Khoryati ; Pierre Duffau ; Marie Kostine ; Cécile Contin-Bordes ; Patrick Blanco ; Thierry SchaeverbekeTocilizumab treatment decreases circulating myeloid dendritic cells and monocytes, 2 components of the myeloid lineage.
001A16 (2011) Tsutomu Takeuchi [Japon] ; Yoshiya Tanaka ; Koichi Amano ; Daisuke Hoshi ; Masao Nawata ; Hayato Nagasawa ; Eri Sato ; Kazuyoshi Saito ; Yuko Kaneko ; Shunsuke Fukuyo ; Takahiko Kurasawa ; Kentaro Hanami ; Hideto Kameda ; Hisashi YamanakaClinical, radiographic and functional effectiveness of tocilizumab for rheumatoid arthritis patients--REACTION 52-week study.
001A24 (2012) Hiroki Wakabayashi [Japon] ; Masahiro Hasegawa ; Yosuke Nishioka ; Akihiro Sudo ; Kusuki NishiokaWhich subgroup of rheumatoid arthritis patients benefits from switching to tocilizumab versus etanercept after previous infliximab failure? A retrospective study.
001B22 (2011) Hisashi Yamanaka [Japon] ; Yoshiya Tanaka ; Eisuke Inoue ; Daisuke Hoshi ; Shigeki Momohara ; Kentaro Hanami ; Naoki Yunoue ; Kazuyoshi Saito ; Kouichi Amano ; Hideto Kameda ; Tsutomu TakeuchiEfficacy and tolerability of tocilizumab in rheumatoid arthritis patients seen in daily clinical practice in Japan: results from a retrospective study (REACTION study).
001B66 (2010) Norihiro Nishimoto [Japon] ; Nobuhiro TakagiAssessment of the validity of the 28-joint disease activity score using erythrocyte sedimentation rate (DAS28-ESR) as a disease activity index of rheumatoid arthritis in the efficacy evaluation of 24-week treatment with tocilizumab: subanalysis of the SATORI study.
001B70 (2010) Hiroaki Matsuno [Japon]Etanercept response in patients with rheumatoid arthritis after secondary loss of efficacy of infliximab.
001B73 (2010) Masanobu Horikoshi [Japon] ; Takeshi Suzuki ; Makoto Sugihara ; Yuya Kondo ; Hiroto Tsuboi ; Takeaki Uehara ; Maasa Hama ; Kaoru Takase ; Shigeru Ohno ; Yoshiaki Ishigatsubo ; Yuri Yoshida ; Akira Sagawa ; Kei Ikeda ; Toshiyuki Ota ; Isao Matsumoto ; Satoshi Ito ; Takayuki SumidaComparison of low-field dedicated extremity magnetic resonance imaging with articular ultrasonography in patients with rheumatoid arthritis.
001C11 (2010) Vibeke Strand [États-Unis] ; Jasvinder A. SinghNewer biological agents in rheumatoid arthritis: impact on health-related quality of life and productivity.
001C20 (2010) Patrick Garnero [France] ; Elizabeth Thompson ; Thasia Woodworth ; Josef S. SmolenRapid and sustained improvement in bone and cartilage turnover markers with the anti-interleukin-6 receptor inhibitor tocilizumab plus methotrexate in rheumatoid arthritis patients with an inadequate response to methotrexate: results from a substudy of the multicenter double-blind, placebo-controlled trial of tocilizumab in inadequate responders to methotrexate alone.
001C25 (2009) Toshio Tanaka [Japon] ; Yusuke Kuwahara ; Yoshihito Shima ; Toru Hirano ; Mari Kawai ; Masako Ogawa ; Junsuke Arimitsu ; Keisuke Hagihara ; Masashi Narazaki ; Atsushi Ogata ; Ichiro Kawase ; Tadamitsu KishimotoSuccessful treatment of reactive arthritis with a humanized anti-interleukin-6 receptor antibody, tocilizumab.
001C33 (2010) Shin-Ya Kawashiri [Japon] ; Atsushi Kawakami ; Naoki Iwamoto ; Keita Fujikawa ; Toshiyuki Aramaki ; Mami Tamai ; Kazuhiko Arima ; Kunihiro Ichinose ; Makoto Kamachi ; Satoshi Yamasaki ; Hideki Nakamura ; Tomoki Origuchi ; Hiroaki Ida ; Katsumi EguchiSwitching to the anti-interleukin-6 receptor antibody tocilizumab in rheumatoid arthritis patients refractory to antitumor necrosis factor biologics.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/PubMed/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i -k "Health Status" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/MedMesh.i  \
                -Sk "Health Status" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    PubMed
   |étape=   Curation
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Health Status
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021